Former US president Joe Biden, 82, has been diagnosed with an “aggressive form” of prostate cancer, and it has spread to his bones. His personal office said Sunday (May 18) the cancer appeared to be ...

Other tools include blood tests for prostate-specific antigen (PSA, which is often elevated in prostate cancer patients), physical examinations (such as a digital rectal examination), and imaging of ...

Open-label phase Ib/II study of cetuximab (CET) plus LY3214996 with or without abemaciclib in patients (pts) with anti-EGFR-refractory metastatic colorectal cancer (mCRC). Survival of patients (pts) ...

A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission. The findings from the ...

This prospective cohort study suggests patients with localized rectal cancer that are classified as low-risk based on MRI characteristics can forego neoadjuvant chemoradiation with an acceptably low ...

The findings from the UK-wide trial—released at the ESTRO 2025 conference in Vienna this week—reported high rates of complete response to treatment among rectal cancer patients participating ...

Regulatory T-cells, or Treg cells, regulate the body's immune response to cancer and acute inflammation from infection or tissue injury. In cancer, Tregs suppress anti-tumor immune responses and ...

Research, headed by teams at Trinity College Dublin and University College Dublin, has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body ...

MRI, and PET-CT, “we believe that ctDNA represents the next major pivotal advancement in monitoring and eventually better understanding cancer diagnostics,” Magee said. Commenting on the study ...

Anal fistulas can be painful and persistent. Here’s what causes them and the best treatment options to manage or eliminate ...

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...